9:32 am ISIS Pharm reports final Phase 2 data on ISIS-APOCIII Rx in patients with high triglycerides taking fibrates; reductions of up to 64% in triglycerides achieved
View todays social media effects on ISIS
View the latest stocks trending across Twitter. Click to view dashboard
See who Isis is hiring next, click here to view
